Abstract

It is generally accepted that alterations in metabolism are critical for the metastatic process; however, the mechanisms by which these metabolic changes are controlled by the major drivers of the metastatic process remain elusive. Here, we found that S100 calcium-binding protein A4 (S100A4), a major metastasis-promoting protein, confers metabolic plasticity to drive tumor invasion and metastasis of non-small cell lung cancer cells. Investigating how S100A4 regulates metabolism, we found that S100A4 depletion decreases oxygen consumption rates, mitochondrial activity, and ATP production and also shifts cell metabolism to higher glycolytic activity. We further identified that the 49-kDa mitochondrial complex I subunit NADH dehydrogenase (ubiquinone) Fe-S protein 2 (NDUFS2) is regulated in an S100A4-dependent manner and that S100A4 and NDUFS2 exhibit co-occurrence at significant levels in various cancer types as determined by database-driven analysis of genomes in clinical samples using cBioPortal for Cancer Genomics. Importantly, we noted that S100A4 or NDUFS2 silencing inhibits mitochondrial complex I activity, reduces cellular ATP level, decreases invasive capacity in three-dimensional growth, and dramatically decreases metastasis rates as well as tumor growth in vivo Finally, we provide evidence that cells depleted in S100A4 or NDUFS2 shift their metabolism toward glycolysis by up-regulating hexokinase expression and that suppressing S100A4 signaling sensitizes lung cancer cells to glycolysis inhibition. Our findings uncover a novel S100A4 function and highlight its importance in controlling NDUFS2 expression to regulate the plasticity of mitochondrial metabolism and thereby promote the invasive and metastatic capacity in lung cancer.

Highlights

  • It is generally accepted that alterations in metabolism are critical for the metastatic process; the mechanisms by which these metabolic changes are controlled by the major drivers of the metastatic process remain elusive

  • The results showed that the mitochondrial complex I activity in tissues from the shS100A4- and shNDUFS2-injected group was dramatically decreased compared with the activity in the shCont cell–injected tumor tissues (Fig. 6B)

  • It is recognized that these metabolic changes are due to the select pressures such as limited nutrients and the availabilities of oxygen that the metastatic cancer cells encounter due to the interaction of cancer cells with the tumor microenvironment as well as during the discrete steps of metastasis cascade [8, 31]

Read more

Summary

ARTICLE cro

Lili Liu‡1, Lei Qi‡, Teresa Knifley‡, Dava W. Piecoro§, Piotr Rychahou‡¶, Jinpeng Liu‡ʈ, Mihail I. Mitov‡, Jeremiah Martin‡¶, Chi Wang‡ʈ, Jianrong Wu‡ʈ, Heidi L. O’Connor‡ ‡‡2, and Min Chen‡§§3 From the ‡Markey Cancer Center and the Departments of §Pathology and Laboratory Medicine, ¶Surgery, ʈBiostatistics, **Chemistry, ‡‡Molecular and Cellular Biochemistry, and §§Toxicology and Cancer Biology, University of Kentucky, Lexington, Kentucky 40536

Edited by Alex Toker
Results
Discussion
Cell lines and reagents
Mitochondrial stress test and glycolysis stress test
In vivo tumor growth and spontaneous metastasis assays
Statistical analysis
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call